Lexeo Therapeutics (LXEO) Gains from Investment Securities (2022 - 2023)
Historic Gains from Investment Securities for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to $105000.0.
- Lexeo Therapeutics' Gains from Investment Securities fell 277.78% to $105000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $425000.0, marking a year-over-year change of. This contributed to the annual value of $410000.0 for FY2024, which is 352.94% down from last year.
- Per Lexeo Therapeutics' latest filing, its Gains from Investment Securities stood at $105000.0 for Q4 2023, which was down 277.78% from $107000.0 recorded in Q3 2023.
- Lexeo Therapeutics' 5-year Gains from Investment Securities high stood at $110000.0 for Q1 2023, and its period low was $36000.0 during Q3 2022.